Skip to main content
Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

< Back to Article

Fig 1.

The constituents of neuroprotective sub-fractions from SCT in previous study.

(tR represents their retention time in UPLC).

More »

Fig 1 Expand

Fig 2.

The DPPH clearance percentages of active sub-fractions.

Data were expressed as mean ± S.E.M. from the data obtained from three independent experiments (n = 3). NS represents the mean of group has no significant different with the mean of control group.

More »

Fig 2 Expand

Fig 3.

The inhibition percentages of active sub-fractions on AChE.

Data were expressed as mean ± S.E.M. obtained from three independent experiments (n = 3). NS represents the mean of group has no significant difference compared to the mean of control group.

More »

Fig 3 Expand

Fig 4.

The inhibition percentages of active sub-fractions on MAOs.

Data were expressed as mean ± S.E.M. obtained from three independent experiments (n = 3). NS represents the mean of group showed no significant difference with the mean of control group.

More »

Fig 4 Expand

Fig 5.

The inhibition percentages of active sub-fractions on NMDAR-mediated current.

Data were expressed as mean ± S.E.M. D-AP5 group: n = 4, other groups: n = 3. NS represents the mean of group has no significant different with the mean of control group.

More »

Fig 5 Expand

Fig 6.

The intersection of targets from constituents and diseases.

AD: Alzheimer‘s Disease; PD: Parkinson’s Disease; ALS: Amyotrophic Lateral Sclerosis; SCA: Spinocerebellar Ataxia; LBD: Lewy Body Dementia; FTD: Frontotemporal Dementia; HD: Huntington’s Disease.

More »

Fig 6 Expand

Table 1.

Overlapping targets of constituents and AD/PD.

More »

Table 1 Expand

Fig 7.

Enrichment analyses for constituents-AD/PD common targets: Biological process.

More »

Fig 7 Expand

Fig 8.

Enrichment analyses for constituents-AD/PD common targets: Molecular function and cellular component.

More »

Fig 8 Expand

Fig 9.

Enrichment analyses for constituents-AD/PD common targets: KEGG pathway.

More »

Fig 9 Expand

Fig 10.

SCT-sub-fraction-constituents-targets-disease network diagram.

More »

Fig 10 Expand

Table 2.

The results of topological analysis for the network.

More »

Table 2 Expand

Fig 11.

Surflex-dock results of SCT constituents with key targets in total score.

More »

Fig 11 Expand

Fig 12.

Constituents from SCT with their possible targets predicted by total score in surflex-dock.

More »

Fig 12 Expand